1-3 of 3
Gareth Morgan
Close
Sort by
Journal Articles

Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level

Carolina Schinke, Alexandra M. Poos, Michael Bauer, Lukas John, Sarah Johnson, Shayu Deshpande, Luis Carrillo, Daisy Alapat, Leo Rasche, Sharmilan Thanendrarajan, Maurizio Zangari, Samer Al Hadidi, Frits van Rhee, Faith Davies, Marc S. Raab, Gareth Morgan, Niels Weinhold
Journal: Blood Advances
Blood Adv (2022) 6 (22): 5873–5883.
https://doi.org/10.1182/bloodadvances.2022007217
Published: 2022
Includes: Supplemental data
Journal Articles

Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma

Christie P. M. Verkleij, Marloes E. C. Broekmans, Mark van Duin, Kristine A. Frerichs, Rowan Kuiper, A. Vera de Jonge, Martin Kaiser, Gareth Morgan, Amy Axel, Rengasamy Boominathan, Jocelyn Sendecki, Amy Wong, Raluca I. Verona, Pieter Sonneveld, Sonja Zweegman, Homer C. Adams, III, Tuna Mutis, Niels W. C. J. van de Donk
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2196–2215.
https://doi.org/10.1182/bloodadvances.2020003805
Published: 2021
Includes: Supplemental data
Journal Articles

Renal outcome in patients with newly diagnosed multiple myeloma: results from the UK NCRI Myeloma XI trial

Clinical Trials & Observations
Ritika Rana, Paul Cockwell, Mark Drayson, Mark Cook, Guy Pratt, David A. Cairns, Charlotte Pawlyn, Graham Jackson, Faith Davies, Gareth Morgan, Jennifer Helen Pinney
Journal: Blood Advances
Blood Adv (2020) 4 (22): 5836–5845.
https://doi.org/10.1182/bloodadvances.2020002872
Published: 2020
Includes: Supplemental data